Aligos Therapeutics, Inc. (ALGS) vs Rockwell Medical, Inc. (RMTI)

A side-by-side comparison of Aligos Therapeutics, Inc. and Rockwell Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALGS vs RMTI

growth of $100 · dividends reinvested · last 6y
ALGS -98.5% (-50.6%/yr)RMTI -93.2% (-36.1%/yr)RMTI compounded faster over this window
050100150200250Start $100202120222023202420252026$1$7
ALGS RMTI

ALGS vs RMTI: by the numbers

  • •ALGS is the larger company ($33M vs $30M market cap).
  • •Both run net losses; RMTI's is the smaller (-7.33% vs -241.01% net margin).
  • •RMTI grew revenue faster over the past five years (2.59% vs -15.85% CAGR).

Metrics side by side

Valuation

MetricALGSRMTI
P/S ratio1.060.43
P/B ratio1.040.85
FCF yieldN/A5.15%

Profitability

MetricALGSRMTI
Gross margin57.46%17.71%
Operating margin-4024.93%-6.52%
Net margin-241.01%-7.33%
ROE-238.24%-14.49%
ROIC-207.97%-9.60%

Growth (annualized)

MetricALGSRMTI
Revenue CAGR (5Y)-15.85%2.59%
Total return CAGR (5Y)-57.15%-33.38%

Frequently asked

Which has grown faster, ALGS or RMTI?
Over the past five years, RMTI grew revenue faster — ALGS at a -15.85% CAGR versus RMTI at 2.59%.
How have ALGS and RMTI total returns compared?
Over the past 5 years, ALGS delivered -57.15% and RMTI delivered -33.38% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.